Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme
- Autores
- Marcaccio, Barbara; Crepaldi, Marco; Postuma, Ian; Simeone, Erica; Guidi, Claretta; Fatemi, Setareh; Ramos, Ricardo Luis; Vercesi, Valerio; Ferrari, Cinzia; Cansolino, Laura; Delgrosso, Elena; Liberto, Riccardo Di; Dondi, Daniele; Vadivel, Dhanalakshmi; Chen, Yi-Wei; Chou, Fong-In; Peir, Jinn-Jer; Wu, Chuan-Jen; Tsai, Hui-Yu; Lee, Jia-Cheng; Portu, Agustina Mariana; Dattoli Viegas, Ana Mailen; González, Sara Josefina; Bortolussi, Silva
- Año de publicación
- 2025
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background: Boron Neutron Capture Therapy (BNCT) is a binary radiotherapy based on the intravenous administration of a borated drug to the patient and the subsequent irradiation with a low-energy neutron beam. The borated formulation accumulates in the tumor cells, and when neutrons interact with boron, a nuclear capture reaction occurs, releasing high-linear energy transfer, short-range particles that cause lethal damage to the cancer cells. Due to its selectivity, BNCT has the potential to treat aggressive brain tumors such as glioblastoma multiforme (GBM), minimizing the side effects. GBM is a brain neoplasia that poses significant treatment challenges due to its invasiveness and resistance to conventional treatments.Purpose: This work aims to find a suitable model for calculating the photon isoeffective dose for GBM, producing ad hoc radiobiological data to feed the model.Methods: To describe adequately the dose-effect relation of BNCT for GBM, the following strategy has been applied 1.We studied the impact of choosing two different photon radiation types (x- or gamma- rays) 2.We assumed that the correct description of the photon-equivalent dose is obtained with the photon isoeffective dose model. This model calculates the photon dose that equals the cell survival obtained with BNCT, taking into account synergism and sub-lethal damage (SLD). 3.Survival curves as a function of the dose for the human GBM U87 cell line were constructed using the clonogenic assays for irradiation with photons (reference), neutron beam, and BNCT. 4.Survival curves were fitted with the modified linear quadratic model, using SLD repair times derived for U87. The radiobiological parameters were determined for the photon isoeffective dose model. 5.The model was applied to a clinical case that received BNCT in Taiwan. Treatment planning has been simulated using an accelerator-based designed neutron beam following the real treatment process and parameters. The results were discussed and compared to the current method, which employs relative biological effectiveness (RBE) factors to obtain BNCT dosimetry in photon-equivalent units.Results: The dose-survival curves have been obtained with two different photon radiation sources as the reference with a thermal neutron beam and neutrons in the presence of boron. The fitted parameters have been obtained as the input for the photon isoeffective dose and the traditional RBE model. For the first time, the radiobiological parameters of a photon isoeffective dose model were produced for BNCT of GBM. Photon isoeffective dose value can differ up to 32% using gamma photons and low-energy x-rays. Photon isoeffective dose values are lower (17%) than the RBE model currently employed in clinical trials.Conclusion: The results highlight the impact of the reference radiation chosen for the isoeffective dose calculation and the importance of feeding the model with the appropriate radiobiological parameters.The dosimetry obtained with the new radiobiological data is consistent with the dose delivered in modern stereotactic radiotherapy, enabling tumor control predictions.
Fil: Marcaccio, Barbara. Universita degli Studi di Pavia; Italia. Universidad Nacional de San Martín; Argentina
Fil: Crepaldi, Marco. Universita degli Studi di Pavia; Italia
Fil: Postuma, Ian. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Simeone, Erica. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Guidi, Claretta. Universita degli Studi di Pavia; Italia
Fil: Fatemi, Setareh. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Ramos, Ricardo Luis. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Vercesi, Valerio. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Ferrari, Cinzia. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Cansolino, Laura. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Delgrosso, Elena. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Liberto, Riccardo Di. San Matteo Polyclinic. Foundation I.R.C.C.S.; Italia
Fil: Dondi, Daniele. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Vadivel, Dhanalakshmi. Universita degli Studi di Pavia; Italia
Fil: Chen, Yi-Wei. Taipei Veterans General Hospital; China
Fil: Chou, Fong-In. National Tsing Hua University; China
Fil: Peir, Jinn-Jer. National Tsing Hua University; China
Fil: Wu, Chuan-Jen. National Tsing Hua University; China
Fil: Tsai, Hui-Yu. National Tsing Hua University; China
Fil: Lee, Jia-Cheng. National Tsing Hua University; China
Fil: Portu, Agustina Mariana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Comisión Nacional de Energía Atómica; Argentina. Universidad Nacional de San Martín; Argentina
Fil: Dattoli Viegas, Ana Mailen. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de San Martín; Argentina. Comisión Nacional de Energía Atómica; Argentina
Fil: González, Sara Josefina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de San Martín; Argentina. Comisión Nacional de Energía Atómica; Argentina
Fil: Bortolussi, Silva. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia - Materia
-
BNCT
Cell survival curves
Dosimetry
Glioblastoma multiforme - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
.jpg)
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/281487
Ver los metadatos del registro completo
| id |
CONICETDig_40026e7add7a2e7cff07b9d45265b6a3 |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/281487 |
| network_acronym_str |
CONICETDig |
| repository_id_str |
3498 |
| network_name_str |
CONICET Digital (CONICET) |
| spelling |
Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiformeMarcaccio, BarbaraCrepaldi, MarcoPostuma, IanSimeone, EricaGuidi, ClarettaFatemi, SetarehRamos, Ricardo LuisVercesi, ValerioFerrari, CinziaCansolino, LauraDelgrosso, ElenaLiberto, Riccardo DiDondi, DanieleVadivel, DhanalakshmiChen, Yi-WeiChou, Fong-InPeir, Jinn-JerWu, Chuan-JenTsai, Hui-YuLee, Jia-ChengPortu, Agustina MarianaDattoli Viegas, Ana MailenGonzález, Sara JosefinaBortolussi, SilvaBNCTCell survival curvesDosimetryGlioblastoma multiformehttps://purl.org/becyt/ford/1.3https://purl.org/becyt/ford/1Background: Boron Neutron Capture Therapy (BNCT) is a binary radiotherapy based on the intravenous administration of a borated drug to the patient and the subsequent irradiation with a low-energy neutron beam. The borated formulation accumulates in the tumor cells, and when neutrons interact with boron, a nuclear capture reaction occurs, releasing high-linear energy transfer, short-range particles that cause lethal damage to the cancer cells. Due to its selectivity, BNCT has the potential to treat aggressive brain tumors such as glioblastoma multiforme (GBM), minimizing the side effects. GBM is a brain neoplasia that poses significant treatment challenges due to its invasiveness and resistance to conventional treatments.Purpose: This work aims to find a suitable model for calculating the photon isoeffective dose for GBM, producing ad hoc radiobiological data to feed the model.Methods: To describe adequately the dose-effect relation of BNCT for GBM, the following strategy has been applied 1.We studied the impact of choosing two different photon radiation types (x- or gamma- rays) 2.We assumed that the correct description of the photon-equivalent dose is obtained with the photon isoeffective dose model. This model calculates the photon dose that equals the cell survival obtained with BNCT, taking into account synergism and sub-lethal damage (SLD). 3.Survival curves as a function of the dose for the human GBM U87 cell line were constructed using the clonogenic assays for irradiation with photons (reference), neutron beam, and BNCT. 4.Survival curves were fitted with the modified linear quadratic model, using SLD repair times derived for U87. The radiobiological parameters were determined for the photon isoeffective dose model. 5.The model was applied to a clinical case that received BNCT in Taiwan. Treatment planning has been simulated using an accelerator-based designed neutron beam following the real treatment process and parameters. The results were discussed and compared to the current method, which employs relative biological effectiveness (RBE) factors to obtain BNCT dosimetry in photon-equivalent units.Results: The dose-survival curves have been obtained with two different photon radiation sources as the reference with a thermal neutron beam and neutrons in the presence of boron. The fitted parameters have been obtained as the input for the photon isoeffective dose and the traditional RBE model. For the first time, the radiobiological parameters of a photon isoeffective dose model were produced for BNCT of GBM. Photon isoeffective dose value can differ up to 32% using gamma photons and low-energy x-rays. Photon isoeffective dose values are lower (17%) than the RBE model currently employed in clinical trials.Conclusion: The results highlight the impact of the reference radiation chosen for the isoeffective dose calculation and the importance of feeding the model with the appropriate radiobiological parameters.The dosimetry obtained with the new radiobiological data is consistent with the dose delivered in modern stereotactic radiotherapy, enabling tumor control predictions.Fil: Marcaccio, Barbara. Universita degli Studi di Pavia; Italia. Universidad Nacional de San Martín; ArgentinaFil: Crepaldi, Marco. Universita degli Studi di Pavia; ItaliaFil: Postuma, Ian. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Simeone, Erica. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Guidi, Claretta. Universita degli Studi di Pavia; ItaliaFil: Fatemi, Setareh. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Ramos, Ricardo Luis. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Vercesi, Valerio. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Ferrari, Cinzia. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Cansolino, Laura. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Delgrosso, Elena. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Liberto, Riccardo Di. San Matteo Polyclinic. Foundation I.R.C.C.S.; ItaliaFil: Dondi, Daniele. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Vadivel, Dhanalakshmi. Universita degli Studi di Pavia; ItaliaFil: Chen, Yi-Wei. Taipei Veterans General Hospital; ChinaFil: Chou, Fong-In. National Tsing Hua University; ChinaFil: Peir, Jinn-Jer. National Tsing Hua University; ChinaFil: Wu, Chuan-Jen. National Tsing Hua University; ChinaFil: Tsai, Hui-Yu. National Tsing Hua University; ChinaFil: Lee, Jia-Cheng. National Tsing Hua University; ChinaFil: Portu, Agustina Mariana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Comisión Nacional de Energía Atómica; Argentina. Universidad Nacional de San Martín; ArgentinaFil: Dattoli Viegas, Ana Mailen. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de San Martín; Argentina. Comisión Nacional de Energía Atómica; ArgentinaFil: González, Sara Josefina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de San Martín; Argentina. Comisión Nacional de Energía Atómica; ArgentinaFil: Bortolussi, Silva. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; ItaliaAmerican Association of Physicists in Medicine2025-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/281487Marcaccio, Barbara; Crepaldi, Marco; Postuma, Ian; Simeone, Erica; Guidi, Claretta; et al.; Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme; American Association of Physicists in Medicine; Medical Physics; 52; 4; 2-2025; 2606-26170094-2405CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://aapm.onlinelibrary.wiley.com/doi/10.1002/mp.17693info:eu-repo/semantics/altIdentifier/doi/10.1002/mp.17693info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2026-02-26T10:26:19Zoai:ri.conicet.gov.ar:11336/281487instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982026-02-26 10:26:20.077CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| dc.title.none.fl_str_mv |
Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme |
| title |
Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme |
| spellingShingle |
Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme Marcaccio, Barbara BNCT Cell survival curves Dosimetry Glioblastoma multiforme |
| title_short |
Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme |
| title_full |
Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme |
| title_fullStr |
Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme |
| title_full_unstemmed |
Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme |
| title_sort |
Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme |
| dc.creator.none.fl_str_mv |
Marcaccio, Barbara Crepaldi, Marco Postuma, Ian Simeone, Erica Guidi, Claretta Fatemi, Setareh Ramos, Ricardo Luis Vercesi, Valerio Ferrari, Cinzia Cansolino, Laura Delgrosso, Elena Liberto, Riccardo Di Dondi, Daniele Vadivel, Dhanalakshmi Chen, Yi-Wei Chou, Fong-In Peir, Jinn-Jer Wu, Chuan-Jen Tsai, Hui-Yu Lee, Jia-Cheng Portu, Agustina Mariana Dattoli Viegas, Ana Mailen González, Sara Josefina Bortolussi, Silva |
| author |
Marcaccio, Barbara |
| author_facet |
Marcaccio, Barbara Crepaldi, Marco Postuma, Ian Simeone, Erica Guidi, Claretta Fatemi, Setareh Ramos, Ricardo Luis Vercesi, Valerio Ferrari, Cinzia Cansolino, Laura Delgrosso, Elena Liberto, Riccardo Di Dondi, Daniele Vadivel, Dhanalakshmi Chen, Yi-Wei Chou, Fong-In Peir, Jinn-Jer Wu, Chuan-Jen Tsai, Hui-Yu Lee, Jia-Cheng Portu, Agustina Mariana Dattoli Viegas, Ana Mailen González, Sara Josefina Bortolussi, Silva |
| author_role |
author |
| author2 |
Crepaldi, Marco Postuma, Ian Simeone, Erica Guidi, Claretta Fatemi, Setareh Ramos, Ricardo Luis Vercesi, Valerio Ferrari, Cinzia Cansolino, Laura Delgrosso, Elena Liberto, Riccardo Di Dondi, Daniele Vadivel, Dhanalakshmi Chen, Yi-Wei Chou, Fong-In Peir, Jinn-Jer Wu, Chuan-Jen Tsai, Hui-Yu Lee, Jia-Cheng Portu, Agustina Mariana Dattoli Viegas, Ana Mailen González, Sara Josefina Bortolussi, Silva |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
BNCT Cell survival curves Dosimetry Glioblastoma multiforme |
| topic |
BNCT Cell survival curves Dosimetry Glioblastoma multiforme |
| purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.3 https://purl.org/becyt/ford/1 |
| dc.description.none.fl_txt_mv |
Background: Boron Neutron Capture Therapy (BNCT) is a binary radiotherapy based on the intravenous administration of a borated drug to the patient and the subsequent irradiation with a low-energy neutron beam. The borated formulation accumulates in the tumor cells, and when neutrons interact with boron, a nuclear capture reaction occurs, releasing high-linear energy transfer, short-range particles that cause lethal damage to the cancer cells. Due to its selectivity, BNCT has the potential to treat aggressive brain tumors such as glioblastoma multiforme (GBM), minimizing the side effects. GBM is a brain neoplasia that poses significant treatment challenges due to its invasiveness and resistance to conventional treatments.Purpose: This work aims to find a suitable model for calculating the photon isoeffective dose for GBM, producing ad hoc radiobiological data to feed the model.Methods: To describe adequately the dose-effect relation of BNCT for GBM, the following strategy has been applied 1.We studied the impact of choosing two different photon radiation types (x- or gamma- rays) 2.We assumed that the correct description of the photon-equivalent dose is obtained with the photon isoeffective dose model. This model calculates the photon dose that equals the cell survival obtained with BNCT, taking into account synergism and sub-lethal damage (SLD). 3.Survival curves as a function of the dose for the human GBM U87 cell line were constructed using the clonogenic assays for irradiation with photons (reference), neutron beam, and BNCT. 4.Survival curves were fitted with the modified linear quadratic model, using SLD repair times derived for U87. The radiobiological parameters were determined for the photon isoeffective dose model. 5.The model was applied to a clinical case that received BNCT in Taiwan. Treatment planning has been simulated using an accelerator-based designed neutron beam following the real treatment process and parameters. The results were discussed and compared to the current method, which employs relative biological effectiveness (RBE) factors to obtain BNCT dosimetry in photon-equivalent units.Results: The dose-survival curves have been obtained with two different photon radiation sources as the reference with a thermal neutron beam and neutrons in the presence of boron. The fitted parameters have been obtained as the input for the photon isoeffective dose and the traditional RBE model. For the first time, the radiobiological parameters of a photon isoeffective dose model were produced for BNCT of GBM. Photon isoeffective dose value can differ up to 32% using gamma photons and low-energy x-rays. Photon isoeffective dose values are lower (17%) than the RBE model currently employed in clinical trials.Conclusion: The results highlight the impact of the reference radiation chosen for the isoeffective dose calculation and the importance of feeding the model with the appropriate radiobiological parameters.The dosimetry obtained with the new radiobiological data is consistent with the dose delivered in modern stereotactic radiotherapy, enabling tumor control predictions. Fil: Marcaccio, Barbara. Universita degli Studi di Pavia; Italia. Universidad Nacional de San Martín; Argentina Fil: Crepaldi, Marco. Universita degli Studi di Pavia; Italia Fil: Postuma, Ian. Istituto Nazionale di Fisica Nucleare; Italia Fil: Simeone, Erica. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia Fil: Guidi, Claretta. Universita degli Studi di Pavia; Italia Fil: Fatemi, Setareh. Istituto Nazionale di Fisica Nucleare; Italia Fil: Ramos, Ricardo Luis. Istituto Nazionale di Fisica Nucleare; Italia Fil: Vercesi, Valerio. Istituto Nazionale di Fisica Nucleare; Italia Fil: Ferrari, Cinzia. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia Fil: Cansolino, Laura. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia Fil: Delgrosso, Elena. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia Fil: Liberto, Riccardo Di. San Matteo Polyclinic. Foundation I.R.C.C.S.; Italia Fil: Dondi, Daniele. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia Fil: Vadivel, Dhanalakshmi. Universita degli Studi di Pavia; Italia Fil: Chen, Yi-Wei. Taipei Veterans General Hospital; China Fil: Chou, Fong-In. National Tsing Hua University; China Fil: Peir, Jinn-Jer. National Tsing Hua University; China Fil: Wu, Chuan-Jen. National Tsing Hua University; China Fil: Tsai, Hui-Yu. National Tsing Hua University; China Fil: Lee, Jia-Cheng. National Tsing Hua University; China Fil: Portu, Agustina Mariana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Comisión Nacional de Energía Atómica; Argentina. Universidad Nacional de San Martín; Argentina Fil: Dattoli Viegas, Ana Mailen. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de San Martín; Argentina. Comisión Nacional de Energía Atómica; Argentina Fil: González, Sara Josefina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de San Martín; Argentina. Comisión Nacional de Energía Atómica; Argentina Fil: Bortolussi, Silva. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia |
| description |
Background: Boron Neutron Capture Therapy (BNCT) is a binary radiotherapy based on the intravenous administration of a borated drug to the patient and the subsequent irradiation with a low-energy neutron beam. The borated formulation accumulates in the tumor cells, and when neutrons interact with boron, a nuclear capture reaction occurs, releasing high-linear energy transfer, short-range particles that cause lethal damage to the cancer cells. Due to its selectivity, BNCT has the potential to treat aggressive brain tumors such as glioblastoma multiforme (GBM), minimizing the side effects. GBM is a brain neoplasia that poses significant treatment challenges due to its invasiveness and resistance to conventional treatments.Purpose: This work aims to find a suitable model for calculating the photon isoeffective dose for GBM, producing ad hoc radiobiological data to feed the model.Methods: To describe adequately the dose-effect relation of BNCT for GBM, the following strategy has been applied 1.We studied the impact of choosing two different photon radiation types (x- or gamma- rays) 2.We assumed that the correct description of the photon-equivalent dose is obtained with the photon isoeffective dose model. This model calculates the photon dose that equals the cell survival obtained with BNCT, taking into account synergism and sub-lethal damage (SLD). 3.Survival curves as a function of the dose for the human GBM U87 cell line were constructed using the clonogenic assays for irradiation with photons (reference), neutron beam, and BNCT. 4.Survival curves were fitted with the modified linear quadratic model, using SLD repair times derived for U87. The radiobiological parameters were determined for the photon isoeffective dose model. 5.The model was applied to a clinical case that received BNCT in Taiwan. Treatment planning has been simulated using an accelerator-based designed neutron beam following the real treatment process and parameters. The results were discussed and compared to the current method, which employs relative biological effectiveness (RBE) factors to obtain BNCT dosimetry in photon-equivalent units.Results: The dose-survival curves have been obtained with two different photon radiation sources as the reference with a thermal neutron beam and neutrons in the presence of boron. The fitted parameters have been obtained as the input for the photon isoeffective dose and the traditional RBE model. For the first time, the radiobiological parameters of a photon isoeffective dose model were produced for BNCT of GBM. Photon isoeffective dose value can differ up to 32% using gamma photons and low-energy x-rays. Photon isoeffective dose values are lower (17%) than the RBE model currently employed in clinical trials.Conclusion: The results highlight the impact of the reference radiation chosen for the isoeffective dose calculation and the importance of feeding the model with the appropriate radiobiological parameters.The dosimetry obtained with the new radiobiological data is consistent with the dose delivered in modern stereotactic radiotherapy, enabling tumor control predictions. |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2025-02 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/281487 Marcaccio, Barbara; Crepaldi, Marco; Postuma, Ian; Simeone, Erica; Guidi, Claretta; et al.; Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme; American Association of Physicists in Medicine; Medical Physics; 52; 4; 2-2025; 2606-2617 0094-2405 CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/281487 |
| identifier_str_mv |
Marcaccio, Barbara; Crepaldi, Marco; Postuma, Ian; Simeone, Erica; Guidi, Claretta; et al.; Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme; American Association of Physicists in Medicine; Medical Physics; 52; 4; 2-2025; 2606-2617 0094-2405 CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://aapm.onlinelibrary.wiley.com/doi/10.1002/mp.17693 info:eu-repo/semantics/altIdentifier/doi/10.1002/mp.17693 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
American Association of Physicists in Medicine |
| publisher.none.fl_str_mv |
American Association of Physicists in Medicine |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1858305856402096128 |
| score |
13.176822 |